| Code | 6170C | ||||||||||
| MA number | EU/1/17/1238/001 | ||||||||||
| Product Form: | aer nas 2x1,8 mg (liek.skl.) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| MAH, country: | Mundipharma Corporation (Ireland) Limited, Ireland | ||||||||||
| Therapeutic Class: | 19 - ANTIDOTA, DETOXICANTIA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | glass container | ||||||||||
| Route of admin.: | Nasal use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(3) hybrid application |
| MA issued: | 10.11.2017 |
| SmPC + PL: |
European Medicines Agency's database
|
| Dokument: |
Nyxoid_Príručka pre zdrav pracovníkov.pdf
|
| Safety feature | Yes |
| Data update: | 04.10.2022 |
